Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 5,090,000 shares, a growth of 16.5% from the February 29th total of 4,370,000 shares. Based on an average daily trading volume, of 2,790,000 shares, the days-to-cover […]
Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Given Consensus Rating of Hold by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
SVB Leerink downgraded shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) from an outperform rating to a market perform rating in a research report released on Monday morning, Marketbeat reports. Several other equities research analysts have also recently commented on the company. Robert W. Baird cut Amylyx Pharmaceuticals from an outperform rating to a neutral […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) was downgraded by investment analysts at SVB Leerink from an “outperform” rating to a “market perform” rating in a research note issued to investors on Monday, Marketbeat Ratings reports. AMLX has been the topic of a number of other reports. The Goldman Sachs Group reissued a “neutral” rating […]
Evercore ISI Reiterates In-Line Rating for Amylyx Pharmaceuticals (NASDAQ:AMLX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.